发明名称 |
Combination therapy using sympathetic nervous system antagonists and endothelin antagonists |
摘要 |
Methods are provided for preventing or inhibiting adverse cardiovascular effects associated with administration of a sympathetic nervous system antagonist in a subject, in which a subject in need thereof is administered a sympathetic nervous system antagonist and an endothelin antagonist. Methods for improving the efficacy of a sympathetic nervous system antagonist are also provided, comprising administering to a subject in need thereof a sympathetic nervous system antagonist together with an endothelin antagonist. Methods of treating prostate cancer or benign prostate hyperplasia (BPH) in a subject are also provided, in which a subject in need thereof is administered a sympathetic nervous system antagonist and an endothelin antagonist. The sympathetic nervous system antagonist may be an alpha-adrenoceptor antagonist, a ganglionic blocking agent or another inhibitor of the actions of the sympathetic nervous system.
|
申请公布号 |
US6635648(B2) |
申请公布日期 |
2003.10.21 |
申请号 |
US20010930138 |
申请日期 |
2001.08.16 |
申请人 |
QUEEN'S UNIVERSITY AT KINGSTON |
发明人 |
ADAMS MICHAEL A.;HEATON JEREMY W.;BRIDGE SUZANNE K. |
分类号 |
A61K31/136;A61K31/137;A61K31/14;A61K31/4168;A61K31/417;A61K31/4172;A61K31/4745;A61K31/517;A61K31/55;A61K45/06;A61P9/12;A61P25/00;(IPC1-7):A61K31/497;A61K31/40 |
主分类号 |
A61K31/136 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|